1. Rubesin SE, Levine MS, Glick SN, Herlinger H, Laufer I. Pseudomembranous colitis with rectosigmoid sparing on barium studies. Radiology. 1989; 170:811–813. PMID:
2916034.
Article
2. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002; 346:334–339. PMID:
11821511.
3. Jung SW, Jeon SW, Do BH, et al. Clinical aspects of rifampicin-associated pseudomembranous colitis. J Clin Gastroenterol. 2007; 41:38–40. PMID:
17198063.
Article
4. Chen TC, Lu PL, Lin WR, Lin CY, Wu JY, Chen YH. Rifampin-associated pseudomembranous colitis. Am J Med Sci. 2009; 338:156–158. PMID:
19561451.
Article
5. Akbar DH, Al-Shehri HZ, Al-Huzali AM, Falatah HI. A case of rifampicin induced pseudomembraneous colitis. Saudi Med J. 2003; 24:1391–1393. PMID:
14710291.
6. Moriarty HJ, Scobie BA. Pseudomembranous colitis in a patient on rifampicin and ethambutol. N Z Med J. 1980; 91:294–295. PMID:
6930008.
7. Klaui H, Leuenberger P. Pseudomembranous colitis due to rifampicin. Lancet. 1981; 2:1294. PMID:
6118708.
Article
8. George RH. Pseudomembranous colitis probably due to rifampicin. Lancet. 1980; 1:1304. PMID:
6104109.
Article
9. Park JY, Kim JS, Jeung SJ, Kim MS, Kim SC. A case of pseudomembranous colitis associated with rifampin. Korean J Intern Med. 2004; 19:261–265. PMID:
15683116.
Article
10. Nakajima A, Yajima S, Shirakura T, et al. Rifampicin-associated pseudomembranous colitis. J Gastroenterol. 2000; 35:299–303. PMID:
10777161.
Article
11. Barbut F, Decrbu D, Burghoffer B, et al. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother. 1999; 43:2607–2611. PMID:
10543736.
12. Bendle JS, James PA, Bennett PM, Avison MB, Macgowan AP, Al-Shafi KM. Resistance determinants in strains of Clostridium difficile from two geographically distinct populations. Int J Antimicrob Agents. 2004; 24:619–621. PMID:
15555889.
Article
13. LaHatte LJ, Schuman BM. Haubrich WS, Schaffner F, Berk JE, editors. Antibiotic-associated injury to the gut. Bockus Gastroenterology. 1995. 5th ed. Philadelphia: WB Saunders;p. 1657–1671.
14. Fournier G, Orgiazzi J, Lenoir B, Dechavanne M. Pseudomembranous colitis probably due to rifampicin. Lancet. 1980; 1:101. PMID:
6101404.
Article
15. Woo ML, Cho JH, Kim JH, et al. Anti-tuberculosis agents induced Pseudomembranous colitis treated with maintaining anti-tuberculosis drugs. Korean J Gastrointest Endosc. 2009; 38:47–51.
16. Burbige EJ, Radigan JJ. Antibiotic-associated colitis with normal-appearing rectum. Dis Colon Rectum. 1981; 24:198–200. PMID:
7227136.
Article
17. Tedesco FJ, Corless JK, Brownstein RE. Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology. 1982; 83:1259–1260. PMID:
7129030.
Article
18. Gonenne J, Pardi DS. Clostridium difficile: an update. Compr Ther. 2004; 30:134–140. PMID:
15793312.
Article